LGNZZ   $0.1351  -15.56% Market Closed

Ligand Pharmaceuticals, Inc.
Total Cash 226.93M
totalCashPerShare 12.422
EBITDA 43.06M
Total Debt 7.64M
quickRatio 14.307
currentRatio 16.82
Total Revenue 133.48M
debtToEquity 0.986
Revenue/Share 7.561
ROA 0.00614
ROE 0.058530003
grossProfits
freeCashflow -18.11M
operatingCashflow 47.76M
earningsGrowth
revenueGrowth 0.575
grossMargins 0.75027
ebitdaMargins 0.32259
operatingMargins 0.17796
profitMargins 0.31573
enterpriseValue
forwardPE
floatShares 17.89M
sharesOutstanding
sharesShort
sharesShortPriorMonth
dateShortInterest
sharesPercentSharesOut
heldPercentInsiders
heldPercentInstitutions
Short Ratio help_outline
shortPercentOfFloat
impliedSharesOutstanding
bookValue 42.822
Price To Book help_outline 0.00
earningsQuarterlyGrowth
netIncomeToCommon 42.14M
trailingEps
forwardEps
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 1
lastUpdated Nov. 7, 2024, 12:35 a.m.